MedTrace Logo

Clopidogrel High Dose Evaluation for the Patient With Coronary Artery Disease in Japan

NCT01069302 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2016-01-11

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of high dose clopidogrel as the antiplatelet therapy on inhibition of platelet aggregation in Japanese patients scheduled for percutaneous coronary intervention due to ischemic heart disease.

Conditions

Interventions

DRUG

Clopidogrel

Clopidogrel loading 600mg and maintenance 150mg for 7days

DRUG

Clopidogrel

Clopidogrel loading 600mg and maintenance 75mg for 7days

DRUG

Clopidogrel

Clopidogrel loading 300mg and maintenance 150mg for 7days

DRUG

Clopidogrel

Clopidogrel loading 300mg and maintenance 75mg for 7days

Sponsors & Collaborators

  • Takeshi Morimoto

    lead OTHER

Principal Investigators

  • Takeshi Kimura, MD · Professor of Medicine, Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2011-11-30
Completion
2011-12-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01069302 on ClinicalTrials.gov